[PDF][PDF] VPS35 mutations in Parkinson disease
…, JO Aasly, PR Burkhard, R Djaldetti… - The American Journal of …, 2011 - cell.com
The identification of genetic causes for Mendelian disorders has been based on the collection
of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals…
of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals…
[HTML][HTML] The natural history of multiple system atrophy: a prospective European cohort study
…, R Dodel, C Sampaio, M Coelho, R Djaldetti… - The lancet …, 2013 - thelancet.com
Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative
movement disorder that is characterised by autonomic failure, cerebellar ataxia, and …
movement disorder that is characterised by autonomic failure, cerebellar ataxia, and …
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease
…, S Vukosavic, R Djaldetti… - Proceedings of the …, 2001 - National Acad Sciences
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damages dopaminergic neurons in the
substantia nigra pars compacta (SNpc) as seen in Parkinson's disease. Here, we show that …
substantia nigra pars compacta (SNpc) as seen in Parkinson's disease. Here, we show that …
The mystery of motor asymmetry in Parkinson's disease
R Djaldetti, I Ziv, E Melamed - The Lancet Neurology, 2006 - thelancet.com
The motor symptoms of Parkinson's disease are predominantly due to progressive
degeneration of nigral dopaminergic neurons. In most cases there is a substantial asymmetry of …
degeneration of nigral dopaminergic neurons. In most cases there is a substantial asymmetry of …
The parkinsonian toxin MPTP: action and mechanism
…, V Jackson-Lewis, R Djaldetti… - Restorative …, 2000 - content.iospress.com
MPTP causes damage to substantia nigra pars compacta (SNpc) dopaminergic (DA) neurons
as seen in Parkinsons disease (PD). After sys-temic administration of MPTP, its active …
as seen in Parkinsons disease (PD). After sys-temic administration of MPTP, its active …
Increased plasma endothelin-1 in acute ischemic stroke.
I Ziv, G Fleminger, R Djaldetti, A Achiron, E Melamed… - Stroke, 1992 - Am Heart Assoc
Endothelins are a recently discovered group of most powerful vasoconstrictor peptides.
Endothelin-1 is produced by endothelial cells, and endothelin-3 is derived from neuronal tissue. …
Endothelin-1 is produced by endothelial cells, and endothelin-3 is derived from neuronal tissue. …
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry
…, MT Pellecchia, P Barone, R Djaldetti… - Movement …, 2010 - Wiley Online Library
Multiple system atrophy (MSA) is a Parkinson's Disease (PD)‐like α‐synucleinopathy clinically
characterized by dysautonomia, parkinsonism, cerebellar ataxia, and pyramidal signs in …
characterized by dysautonomia, parkinsonism, cerebellar ataxia, and pyramidal signs in …
Red flags for multiple system atrophy
The clinical diagnosis of multiple system atrophy (MSA) is fraught with difficulty and there
are no pathognomonic features to discriminate the parkinsonian variant (MSA‐P) from …
are no pathognomonic features to discriminate the parkinsonian variant (MSA‐P) from …
Camptocormia (bent spine) in patients with Parkinson's disease—characterization and possible pathogenesis of an unusual phenomenon
R Djaldetti, R Mosberg‐Galili, H Sroka… - … : official journal of the …, 1999 - Wiley Online Library
Camptocormia is characterized by severe forward flexion of the thoracolumbar spine which
increases while walking and disappears in the recumbent position. We describe for the first …
increases while walking and disappears in the recumbent position. We describe for the first …
Cannabis (medical marijuana) treatment for motor and non–motor symptoms of Parkinson disease: An open-label observational study
…, TA Treves, Y Roditi, R Djaldetti - Clinical …, 2014 - journals.lww.com
Objective The use of cannabis as a therapeutic agent for various medical conditions has
been well documented. However, clinical trials in patients with Parkinson disease (PD) have …
been well documented. However, clinical trials in patients with Parkinson disease (PD) have …